Performance Evaluation of the Sysmex Haematology XN Modular System
Overview
Affiliations
Background: The Sysmex XN haematology instrument performs automatic reflex testing, depending on sample results. A nucleated red blood cell (NRBC) count is provided on all samples. The instrument has a smaller footprint (34%) than previous Sysmex XE analysers.
Methods: An evaluation comparing all results to the Sysmex XE-2100 and manual microscopic differential and morphology (n=390) was performed followed by a workflow study of 1000 samples to compare speed of operation and number of blood films reviews required from both systems.
Results: The new features on the instrument are: (1) white cell and NRBC channel, all samples include the NRBC count; (2) white cell precursor channel: false positive flags for blasts, abnormal lymphocytes and atypical lymphocytes are reduced significantly without a statistical increase of false negatives; (3) low white cell count mode: suggested setting of <0.5×10(9)/l. An extended count is more precise and provides an accurate differential. Fluorescent platelet count is performed in a dedicated channel. If the red cell or platelet size histograms are abnormal or if the platelet count is low, then a fluorescent platelet count is automatically performed. Good correlation with the XE-2100 and manual differential was found and the improved results compared to the reference flow cytometric analysis for platelet counts, especially below 30×10(9)/l (XE-2100, R(2)=0.500; XN, R(2)=0.875).
Conclusion: The XN showed reduced sample turnaround time of 10% and reduced number of blood films for examination, 49% less than the XE-2100 without loss of sensitivity with more precise and accurate results on low cell counts.
Steibel K, Joris M, Clichet V, Charbonnier A, Desoutter J, Marolleau J Int J Lab Hematol. 2024; 47(1):41-50.
PMID: 39231460 PMC: 11725552. DOI: 10.1111/ijlh.14358.
Performance evaluation of the new Sysmex XR-Series haematology analyser.
Fujimaki K, Hummel K, Magonde I, Dammert K, Hamaguchi Y, Mintzas K Pract Lab Med. 2024; 39:e00370.
PMID: 38404527 PMC: 10884972. DOI: 10.1016/j.plabm.2024.e00370.
Ho S, Tan S, Mazlan M, Iberahim S, Lee Y, Hassan R Diagnostics (Basel). 2023; 13(14).
PMID: 37510189 PMC: 10378205. DOI: 10.3390/diagnostics13142445.
Applications of Artificial Intelligence in Philadelphia-Negative Myeloproliferative Neoplasms.
Elsayed B, Elshoeibi A, Elhadary M, Ferih K, Elsabagh A, Rahhal A Diagnostics (Basel). 2023; 13(6).
PMID: 36980431 PMC: 10047906. DOI: 10.3390/diagnostics13061123.
Yamaguchi A, Wada K, Moriuchi R, Tao K, Konishi H, Tamaru Y Intern Med. 2023; 62(19):2795-2802.
PMID: 36792196 PMC: 10602826. DOI: 10.2169/internalmedicine.0945-22.